Metabolomics is the study of metabolites formed due to cellular processes, i.e. the aftereffects of cellular processes. The complete set of the small-molecule products of cellular processes is known as the metabolome of the given biological sample. The sample can range from cell samples to whole organisms, and its metabolome can vary accordingly. Studying the metabolome of a biological system allows scientists to understand the connections within the cellular processes as well as the interrelationship between the cellular processes and the external environment.
Browse Full Global Metabolomics Market Report with TOC :http://www.mrrse.com/metabolomics-market
With advances in genetics, the demand for metabolomics is growing, as the genotypic cause of an interaction that leads to the production of a particular metabolite can be discovered and assessed with much more clarity with the help of genetic studies. This is made possible due to the close relationship between the phenotype of the biological sample and the nature and composition of the metabolome. Thus, the increasing demand for metabolomics from life sciences research has emerged as a major driver for the global metabolomics market.
According to a market study recently added to the market intelligence database of Market Research Reports Search Engine (MRRSE), the global metabolomics market is expected to exhibit a robust 17.1% CAGR from 2016 to 2024. The market is expected to be valued at close to US$2.5 bn by the end of the forecast period.
Rising Demand for Personalized Medicine Drives Global Metabolomics Market
The increasing incorporation of advanced technology into medicine has made the possibility of personalized medicine tangible in recent years. The rapid development of the personalized medicine sector is evident in the fact that the first ever International Congress on Personalized Health Care was held in mid-June 2016 in Montreal.
One of the major points highlighted in the Congress was the enhancement brought about in medical science by the use of genomics and genotypic studies. If personalized medicine is to become reality, metabolomics has a large role to play in its development. Metabolomics is a highly convenient tool for life sciences research, since it is reasonably quick and can be scaled and customized according to the nature of the biological sample in question. This is expected to become a strong driver for the global metabolomics market in the coming years as government funding for life sciences research grows.
HPLC Separation Dominates Global Metabolomics Market
By technique, the global metabolomics market can be segmented into separation and detection techniques, with the former responsible for separating the various metabolites in a metabolome and the latter responsible for identifying each component. High-performance liquid chromatography (HPLC) is a widely used separation technique and comprises the largest technology segment of the global metabolomics market. Other separation techniques in the metabolomics market include gas chromatography, capillary electrophoresis, and ultra-performance liquid chromatography, while nuclear magnetic resonance spectroscopy and mass spectrometry are the major detection techniques.
Browse the full Press Release of Global Metabolomics Market at http://www.mrrse.com/global-metabolomics-market
By geography, the global metabolomics market is concentrated in developed regions such as North America and Europe. The firm support shown by governments in these regions to advances in healthcare technology is responsible for this. The important role played by Asia Pacific in the life sciences industry is expected to drive the APAC metabolomics market in the coming years, though North America and Europe will remain the dominant regional players.